Molecular Partners AG

Wagistrasse 14, 8952 Schlieren
Molecular Partners AG   link
Ort: Schlieren

Molecular Partners is developing novel binding proteins for applications in biotechnology, diagnostics and therapeutics. These binding molecules are based on the proprietary DRP technology (Designed Repeat Protein technology) and equal the target binding properties of antibodies but feature superior stability and expression. DARPins (Designed Ankyrin Repeat Proteins) are the most advanced class of designed repeat proteins, which has been generated by the DRP technology and DARPins have been successfully used in different biological and medical applications. Year of foundation: 2004



Website Preview